Management of kidney stones by giving decoction orally.
- Conditions
- Health Condition 1: N202- Calculus of kidney with calculus of ureter
- Registration Number
- CTRI/2022/02/040023
- Lead Sponsor
- Mali Shubham Sunil
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Patients fulfilling the diagnostic criteria which are based on signs and
symptoms of Urolithiasis will be selected
for study.
Patients with size of calculus less than < 10 mm.
Patients having calculus at Kidney, Ureter, Bladder.
Patients willing to participate in clinical trial with written consent.
Pregnancy / Lactation
Patients not willing to participate in trial.
Patients suffering from associated Urolithiasis with following disease will be excluded.
Immunocompromised patient.
Diabetic patients.
Renal failure, congenital disorders like ectopic kidney, horse shoe kidney,
stricture at Uretero Vesical & Uretero Pelvic junction, neoplasm.
Patients having severe hydronephrosis.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Decrease in size of urinary calculi with treatment.Timepoint: Up to 30 days.
- Secondary Outcome Measures
Name Time Method Signs and symptoms of Urolithiasis will improve with treatment.Timepoint: Up to 30 days.